Antiarrhythmic drugs

The optimal rhythm management strategy for people with non-paroxysmal ( persistent or long-standing persistent ) atrial fibrilation is currently not...


Catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy can be challenging because of the complexity of underlying...


Although there are many different antiarrhythmic drugs approved for rhythm management of atrial fibrillation, little comparative effectiveness data exist to...


Very frequent premature ventricular complexes ( PVCs ) may be a reversible cause of dilated cardiomyopathy. A study has reviewed...


The efficacy of short-term antiarrhythmic drugs ( AADs ) use compared with no-AADs prescription after catheter ablation of atrial fibrillation...


The purpose of the study was to describe the associated baseline features of atrial fibrillation patients with heart failure (...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation frequently recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs...


Dronedarone ( Multaq ) is a benzofuran derivative with a pharmacological profile similar to Amiodarone but has a more rapid...


Antiarrhythmic drugs ( AADs ) and anticoagulation are mainstays of atrial fibrillation ( AF ) treatment. A study has assessed...


Symptoms are a major driver for patients with atrial fibrillation to seek medical attention and are important to titrate atrial...


Among patients with untreated paroxysmal atrial fibrillation, treatment with radiofrequency ablation resulted in a lower rate of abnormal atrial rhythms...


Before initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of atrial fibrillation is recommended. ( Class I; Level...


Little is known in clinical practice about antiarrhythmic drugs ( AADs ) use in patients with atrial fibrillation ( particularly...


Health professionals are advised that the Product Information for Quetiapine has been updated to include additional information regarding risks of...


Pharmacological rhythm control ( often including electrical or pharmacological cardioversion ) is an integral part of therapy for atrial fibrillation...


Atrial fibrillation is the most common rhythm disorder seen in clinical practice. Antiarrhythmic drugs are effective for reduction of recurrence...


The American Association for Thoracic Surgery ( AATS ) has released new evidence-based guidelines for the prevention and treatment of...


In final draft guidance NICE ( National Institute for Health and Care Excellence ) has defined which heart devices (...


Cerdelga ( Eliglustat ), a novel glucosylceramide analog given orally, was designed to partially inhibit the enzyme glucosylceramide synthase, which...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs...